China Health Technology Group Holding Company Limited (HKG:1069)
0.4250
-0.0250 (-5.56%)
At close: Feb 13, 2026
HKG:1069 Revenue
In the fiscal year ending June 30, 2025, China Health Technology Group Holding Company had annual revenue of 90.22M CNY with 89.50% growth. China Health Technology Group Holding Company had revenue of 59.10M in the half year ending June 30, 2025, with 65.57% growth.
Revenue
90.22M CNY
Revenue Growth
+89.50%
P/S Ratio
0.44
Revenue / Employee
3.11M CNY
Employees
29
Market Cap
43.74M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 90.22M | 42.61M | 89.50% |
| Jun 30, 2024 | 47.61M | -11.11M | -18.92% |
| Jun 30, 2023 | 58.72M | 51.96M | 769.11% |
| Jun 30, 2022 | 6.76M | - | - |
| Jun 30, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangxi Copper Company | 573.51B |
| Aluminum Corporation of China | 262.08B |
| China Hongqiao Group | 179.29B |
| Zijin Gold International Company | 28.13B |
| China Huajun Group | 1.34B |
| Wai Chun Bio-Technology | 377.17M |
| Rare Earth Magnesium Technology Group Holdings | 230.20M |
| Zhejiang Chang'an Renheng Technology | 221.09M |